InvestorsHub Logo
Followers 45
Posts 1174
Boards Moderated 0
Alias Born 01/13/2009

Re: None

Thursday, 06/27/2013 7:55:09 PM

Thursday, June 27, 2013 7:55:09 PM

Post# of 345756
Kudos to the Company for running the first line NSCLC trial. Kudos to the Company for running the pancreatic trial. Kudos for running the HCV trial. They did not have to run these trials. They could have stuck with second line NSCLC only. They are trying to find a treatment for these horrible diseases. How can you determine whether something works unless you try? Only if you do nothing, can you not fail. Nothing is different today than it was yesterday. The 2nd line NSCLC has been approved for Phase III - we are going to Phase III! All we need is ONE, repeat ONE indication approval.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News